by Nick Veringmeier | Apr 15, 2025 | Business Development
Why This Vision Should Matter to Anyone Building Biotech in the Netherlands In April 2025, the Dutch government released its long-term vision for biotechnology. It is not a research agenda or a subsidy pitch. It is a coordinated strategy to guide how the Netherlands...
by Nick Veringmeier | Apr 10, 2025 | Business Development, Life Sciences Marketing
Fractional support might sound like a finance term, but in biotech it is simple. You get experienced marketing and business development professionals working as part of your team without the cost of hiring them full time. This is not about an agency assigning a junior...
by Nick Veringmeier | Mar 12, 2025 | Business Development, Life Sciences Marketing, Niet gecategoriseerd
To support entrepreneurs (innovative startups and scale-up companies in the health sector), Top Sector LSH (Health~Holland) provides an arrangement to reimburse 50% of the innovation brokers costs. The reimbursment is to a maximum of €5.000. Innovation...
by Nick Veringmeier | Mar 12, 2025 | Business Development, Life Sciences Marketing
Life science startups, whether you are in biotech, medtech, digital health, or running a CRO, face a core question: should you focus on marketing or business development (BD)? There is no one answer. The balance depends on what you sell, who buys it, and your growth...
by Nick Veringmeier | Feb 5, 2025 | Business Development
February 3, 2025 – Leiden, NLWe’re pleased to announce that Anton Mat has joined JPP Life Sciences Marketing & BD to shape and strengthen our business development (BD) capabilities. Anton Mat is officially putting the BD in JPP Life Sciences Marketing &...
by Nick Veringmeier | Jan 30, 2025 | Business Development
The European Union has finally decided to declutter its regulatory jungle. With its new simplification agenda, the EU aims to strip away excessive bureaucracy, cut costs, and position itself more competitively against the U.S. and China. European biotech has long...
